← Every applicant
Quagen FDA Approvals
25 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| MORPHINE SULFATENew drugJul 7, 2026SOLUTION, ORAL |
| GLYCOPYRROLATENew drugMay 18, 2026SOLUTION, ORAL |
| LIDOCAINE HYDROCHLORIDENew drugMar 20, 2026SOLUTION, ORAL |
| POTASSIUM CHLORIDENew drugDec 22, 2025SOLUTION, ORAL |
| ARIPIPRAZOLENew drugOct 22, 2025SOLUTION, ORAL |
| FLUOCINONIDENew drugFeb 26, 2025SOLUTION, TOPICAL |
| BENZTROPINE MESYLATENew drugFeb 11, 2025TABLET, ORAL |
| GLYCOPYRROLATENew drugJul 10, 2024TABLET, ORAL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINENew drugMar 12, 2024CAPSULE, ORAL |
| RITONAVIRNew drugFeb 16, 2024CAPSULE, ORAL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINENew drugFeb 8, 2024CAPSULE, ORAL |
| BUTALBITAL AND ACETAMINOPHENNew drugFeb 1, 2024TABLET, ORAL |
| BUTALBITAL AND ACETAMINOPHENNew drugJan 18, 2024TABLET, ORAL |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINENew drugJan 18, 2024TABLET, ORAL |
| MEXILETINE HYDROCHLORIDENew drugFeb 27, 2023CAPSULE, ORAL |
| TRIAMCINOLONE ACETONIDENew drugDec 9, 2022PASTE, DENTAL |
| CLOBETASOL PROPIONATENew drugFeb 17, 2022SOLUTION, TOPICAL |
| MYCOPHENOLATE MOFETILNew drugJul 29, 2021FOR SUSPENSION, ORAL |
| PROMETHAZINE HYDROCHLORIDENew drugJul 12, 2021SYRUP, ORAL |
| OXYCODONE HYDROCHLORIDENew drugJun 2, 2021SOLUTION, ORAL |
| LIDOCAINENew drugApr 20, 2021OINTMENT, TOPICAL |
| FLUOCINOLONE ACETONIDENew drugApr 2, 2021OIL, TOPICAL |
| FLUOCINOLONE ACETONIDENew drugApr 2, 2021OIL/DROPS, OTIC |
| FLUOCINOLONE ACETONIDENew drugApr 2, 2021OIL, TOPICAL |
| CYPROHEPTADINE HYDROCHLORIDENew drugFeb 24, 2021TABLET, ORAL |